Search

Search Constraints

You searched for: Author/Creator Johansson, Gunilla

Search Results

1. A cost‐consequence analysis of early detection of AD in the MOPEAD project — A project within the EU research agenda IMI‐2: Other innovative programs and practices. (7th December 2020)

2. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. (19th May 2018)

3. Complementary pre‐screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project. Issue 6 (26th July 2021)

4. Defeating Alzheimer's disease and other dementias: a priority for European science and society. Issue 5 (April 2016)

7. General practitioners' attitude toward early and pre‐dementia diagnosis of AD in five European countries—A MOPEAD project survey. Issue 1 (23rd February 2021)

8. General practitioners' opinion on early and pre‐dementia diagnosis of AD: A MOPEAD project survey in five European countries: Neuropsychiatry and behavioral neurology/Mild cognitive impairment/Early symptomatic disease. (7th December 2020)

9. P1‐588: QUANTIFYING AND DESCRIBING THE NATURAL HISTORY OF AD AND ECONOMIC EFFECTS OF HYPOTHETICAL INTERVENTIONS. (1st July 2019)

10. P3‐304: MODELS OF PATIENT ENGAGEMENT IN ALZHEIMER'S DISEASE (MOPEAD): A EUROPEAN MULTINATIONAL PROJECT TO DEVELOP AND TEST INNOVATIVE PATIENT ENGAGEMENT STRATEGIES. (1st July 2006)